Last updated: December 19, 2022
Sponsor: National Taiwan University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT05656547
202211078RINC
Ages 20-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients undergoing elective craniotomy for brain tumor resection, aneurysm clipping,an intracranial bypass procedure, or microvascular decompression
- age between 20 to 80 yr
Exclusion
Exclusion Criteria:
- Fever, elevated white blood cell or C-reactive protein
- Impaired liver function, eg. AST or ALT >100; liver cirrhosis > Child B class
- Impaired renal function, cGFR< 60 ml/min/1.73 m2
- Cardiac dysfunction, such as heart failure > NYHA class II
Study Design
Total Participants: 140
Study Start date:
December 12, 2022
Estimated Completion Date:
February 25, 2023
Study Description
Connect with a study center
National Taiwan University Hospital
Taipei, 100
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.